Winner of the DePuy Synthes Resident Craniofacial Award, Ryan Patrick Morton presented his research, Timing of Cranioplasty: A 10-year Single-center Analysis of 754 Patients, during the 2016 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting.
Predicting an increase in demand for the company’s technology, a Stimwave press release notes that this alliance will enables Stimwave to leverage Kairuku’s infrastructure platform and established relationships in the medical field to expand delivery and support for its implantable devices to clinicians, surgery centres and hospitals across the USA.
The US Food and Drug Administration (FDA) has approved Medtronic’s Specify SureScan MRI surgical leads, which are indicated for use as part of Medtronic implanted neurostimulation systems for chronic pain.
University of Texas (UT) Southwestern Medical Center has joined a consortium of seven leading universities to develop new technologies to improve memory in people with traumatic brain injury, mild cognitive impairment, epilepsy, and Alzheimer’s disease.
Researchers have linked high levels of C-reactive protein (CRP) with increased risk for recurrent ischaemic stroke. Already used to measure people’s risk of developing coronary artery disease, the research suggests it could be a useful tool for ischaemic stroke patients as well.
The UK National Institute for Health and Care Excellence (NICE) has published updated guidance for the UK National Health Service (NHS) on the use of mechanical clot retrieval to treat patients who have had an ischaemic stroke.
Sequent Medical has announced that it has completed patient enrolment in its Investigational Device Exemption (IDE) pivotal trial to evaluate the safety and effectiveness of the WEB Aneurysm Embolisation System.
The phenox pREset and pREset LITE thrombectomy devices have been included in the study portfolio of the SITS Open clinical trial. Two other devices are included in the trial.
New data from two separate studies looking at the use of the NeuroBlate system from Monteris for brain lesions were presented at the American Association of Neurological Surgeons (AANS) 84th Annual Scientific Meeting.
The US Patent and Trademark Office (USPTO) has approved a patent providing additional coverage of Neuravi’s therapeutic stent-retriever platform for the endovascular treatment of acute ischaemic stroke. Earlier this year, Neuravi also received a European patent grant for this platform.
Brainlab has enrolled 11, to date, of the expected 30 hospitals and healthcare systems in the national Stereotactic Radiosurgery (SRS) Patient Registry.
Winner of the Louise Eisenhardt Traveling Scholarship, Sophia F Shakur, presented her research—Changes in Pulsatility and Resistance Indices of Cerebral Arteriovenous Malformation Feeder Arteries after Embolization and Surgery—during the 2016 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting.
Abbott is set to acquire St Jude Medical, expanding its portfolio to cover cardiovascular markets such as atrial fibrillation, structural heart and heart failure as well as neuromodulation. The combined company will thus produce devices across cardiovascular, diabetes, vision and neuromodulation markets.
In a study evaluating the safety and feasibility of a combination of proximal internal carotid artery occlusion using a balloon catheter and distal aspiration through an intermediate catheter in stroke patients treated with mechanical thrombectomy with a stent retriever, the investigators report that there was no macroscopic thrombus migration to a new vascular territory.
A new study has concluded that burst spinal cord stimulation is “in general” more effective than tonic stimulation in patients already familiar with spinal cord stimulation.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos